| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.22 | 0.5 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |